ACT PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID1132926120

KRS0000657006

Share capital5,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. WILEŃSKA 14 / 1C, 03-414 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

ACT PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. WILEŃSKA 14 / 1C, 03-414 WARSZAWA

Show on map

NIP

1132926120

REGON

366266480

KRS

0000657006

Legal form

limited liability company

Register Address

UL. WILEŃSKA 14 / 1C, 03-414 WARSZAWA

Date of registration in KRS

2017-01-03

Date of commencement of economic activity

2017-01-03

Act signature

WA.XIV NS-REJ.KRS/7681/25/89/ADE

Pkd codes

47.73.Z - Retail sale of pharmaceutical products

21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products

47.29.Z - Retail trade

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

68.20.Z - Rental and management of own or leased real estate

70.22.Z - Head office activities and management consultancy

73.11.Z - Advertising agency activities

Company authorities

representation authorityMANAGEMENT

representation type

KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE.

MANAGEMENT

Tobiasz Bożydar Migdał

Chairman Of The Board, 34 years old

shareholders

Tobiasz Bożydar Migdał

100% 100 udziałów o łącznej wartości 5000 pln

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Profit (loss) on sale	0,1	0,1	0	-79,6
Gross profit (loss)	0,1	0,1	0	-83,7
EBITDA	0,1	0,1	0	-81,5
Short time liabilities	0,1	0,2	0,2	42,8
Other operating costs	0	0	0	52,8
Equity capital	0,2	0,4	0,4	5,5
Operating profit (EBIT)	0,1	0,1	0	-83,7
Assets	0,3	0,5	0,6	17,5
Net profit (loss)	0,1	0,1	0	-84,7
Cash	0,1	0,3	0,3	26,5
Net income from sale	2,5	2,9	3	3,7
Liabilities and provisions for liabilities	0,1	0,2	0,2	42,8
Working assets	0,3	0,5	0,6	18,7
Other income costs	0	0	0	35,2
Depreciation	0	0	0	0
	%	%	%	p.p.
Profitability of capital	41,4	36,2	5,2	-31
Equity capital to total assets	67,5	67,9	61	-6,9
Gross profit margin	4	4,9	0,8	-4,1
EBITDA Margin	4	5	0,9	-4,1
	Days	Days	Days	Days
Short term commitment turnover cycle	16	21	29	8

Current financial liquidity indicator	2.9135208129882812	3.03171706199646	2.5204925537109375	-0,5
Net dept to EBITDA	-0.9665905833244324	-1.7843947410583496	-12.211796760559082	-10,4